NirogStreet is a technology company.
NirogStreet has raised $19.0M across 3 funding rounds.
NirogStreet has raised $19.0M in total across 3 funding rounds.
NirogStreet has raised $19.0M in total across 3 funding rounds.
NirogStreet's investors include Backstage Capital, Bessemer Venture Partners, Jenny Fielding, Scott Hartley, High Line Venture Partners, Jungle Ventures, Trifecta Growth Equity, Fatih Isbecer, Gokul Rajaram.
NirogStreet is a New Delhi-based healthtech startup founded in 2016 that builds a technology-driven platform focused on Ayurveda and alternative medicine.[1][4][5] It connects patients with certified Ayurvedic doctors for online consultations, personalized treatment plans, medicine delivery, and wellness services while providing practitioners with tools for learning, networking, case discussions, and professional development.[1][3][4] Serving patients seeking holistic, evidence-based Ayurvedic care and healthcare professionals in India and globally, NirogStreet addresses trust and transparency issues in the fragmented Ayurveda sector by standardizing treatments and promoting credibility through tech integration.[2][4] The company has raised $24.8M–$36.8M total funding (latest $3M convertible note in 2023), employs ~250 people, generates ₹66.2 Cr+ revenue (FY24), and shows strong growth via web traffic (283K monthly visits) and recognition as a top Ayurvedic startup.[1][5]
NirogStreet emerged in June 2016 amid challenges in the Indian Ayurveda industry, including lack of trust, transparency, and standardization, which hindered its mainstream adoption.[2][4] Founders Abhishek Gupta, Aradhna Rai, Ram Naumi Kumar, Robin Jha, and Shrey Jain launched the platform (legal entity: Hinirog Healthtech Private Limited) to digitize access to authentic Ayurveda, starting with connections between certified doctors and patients.[3][4] Early focus was on building a community for practitioners via an app for discussions, CMEs, workshops, and research sharing, in collaboration with the Ministry of AYUSH and regulators.[4] Pivotal traction came from expanding to patient services like consultations and medicine delivery, securing incubators, 15+ angel investors, and 10+ VC funds, evolving from a doctor-centric tool to a full ecosystem platform.[3][5]
NirogStreet rides the global surge in holistic wellness and Ayurveda, fueled by post-pandemic demand for natural, preventive healthcare amid rising chronic diseases and skepticism toward allopathic side effects.[1][4] Timing aligns with India's push for traditional medicine via Ministry of AYUSH initiatives and a booming $10B+ Ayurvedic market growing at 15–20% annually, where tech bridges ancient practices (e.g., Charak Samhita) with modern digital health trends like teleconsultations.[2][4] Favorable forces include rising smartphone penetration in India, AI personalization, and investor interest in healthtech (evidenced by $36M+ funding).[5] It influences the ecosystem by elevating Ayurveda's credibility through evidence-based standardization, inspiring peers like Vedix, and shifting consumer behavior toward proactive, tech-accessible alternative medicine.[1][2]
NirogStreet is poised for expansion into global markets and deeper AI-driven personalization, leveraging its doctor network and FY24 revenue momentum to capture more of the Ayurveda boom.[1][5] Trends like integrative medicine, regulatory digitization, and wellness tech (e.g., wearables for dosha tracking) will accelerate growth, potentially pushing toward unicorn status via Series A and international partnerships.[2][4] Its influence may evolve from India-centric platform to a global Ayurveda leader, standardizing holistic care and challenging modern medicine's dominance—reinforcing its mission to make Ayurveda the "first call of treatment" for billions.[4]
NirogStreet has raised $19.0M across 3 funding rounds. Most recently, it raised $12.0M Series B in October 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2022 | $12.0M Series B | Backstage Capital, Bessemer Venture Partners, Jenny Fielding, Scott Hartley, High Line Venture Partners, Jungle Ventures, Trifecta Growth Equity, Fatih Isbecer, Gokul Rajaram | |
| Dec 1, 2021 | $4.0M Series A | Backstage Capital, Jenny Fielding, Scott Hartley, High Line Venture Partners, Fatih Isbecer | |
| Jul 1, 2021 | $3.0M Series A | Backstage Capital, Jenny Fielding, Scott Hartley, High Line Venture Partners, Fatih Isbecer |